Spanish researchers achieve full pancreatic tumor regression in a mouse model study
Pancreatic tumor regression achieved in mice marks a rare and significant breakthrough in one of oncology’s most stubborn challenges. Researchers at Spain’s National Cancer Research Centre induced complete disappearance of established pancreatic tumors by reprogramming the tumor microenvironment, allowing the immune system to recognize and destroy cancer cells. Pancreatic cancer kills the vast majority of patients it affects, with a five-year survival rate below 12%, partly because dense tissue surrounding tumors blocks treatment and hides cancer from immune defenses. While mouse results don’t guarantee human success, this proof of concept signals that full regression in this disease is biologically possible.









